PT1051159E - Composicoes farmaceuticas solidas contendo miltefosina para administracao oral no tratamento de leishmaniose - Google Patents
Composicoes farmaceuticas solidas contendo miltefosina para administracao oral no tratamento de leishmanioseInfo
- Publication number
- PT1051159E PT1051159E PT98904121T PT98904121T PT1051159E PT 1051159 E PT1051159 E PT 1051159E PT 98904121 T PT98904121 T PT 98904121T PT 98904121 T PT98904121 T PT 98904121T PT 1051159 E PT1051159 E PT 1051159E
- Authority
- PT
- Portugal
- Prior art keywords
- treatment
- oral administration
- solid pharmaceutical
- compositions containing
- pharmaceutical compositions
- Prior art date
Links
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 5
- PQLXHQMOHUQAKB-UHFFFAOYSA-N miltefosine Chemical compound CCCCCCCCCCCCCCCCOP([O-])(=O)OCC[N+](C)(C)C PQLXHQMOHUQAKB-UHFFFAOYSA-N 0.000 title abstract 3
- 239000007787 solid Substances 0.000 title abstract 3
- 208000004554 Leishmaniasis Diseases 0.000 abstract 2
- 229960003775 miltefosine Drugs 0.000 abstract 2
- 230000001142 anti-diarrhea Effects 0.000 abstract 1
- 229940124537 antidiarrhoeal agent Drugs 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
- A61K31/685—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols one of the hydroxy compounds having nitrogen atoms, e.g. phosphatidylserine, lecithin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2009—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/485—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Inorganic Chemistry (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Tropical Medicine & Parasitology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/EP1998/000345 WO1999037289A1 (en) | 1998-01-22 | 1998-01-22 | Solid pharmaceutical compositions containing miltefosine for oral administration in the treatment of leishmaniasis |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PT1051159E true PT1051159E (pt) | 2002-09-30 |
Family
ID=8166843
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PT98904121T PT1051159E (pt) | 1998-01-22 | 1998-01-22 | Composicoes farmaceuticas solidas contendo miltefosina para administracao oral no tratamento de leishmaniose |
Country Status (24)
| Country | Link |
|---|---|
| US (1) | US6544551B1 (enExample) |
| EP (1) | EP1051159B1 (enExample) |
| JP (1) | JP2002501015A (enExample) |
| KR (1) | KR100517399B1 (enExample) |
| CN (1) | CN100413492C (enExample) |
| AT (1) | ATE215817T1 (enExample) |
| AU (1) | AU756805B2 (enExample) |
| BR (1) | BR9814772A (enExample) |
| CA (1) | CA2318260C (enExample) |
| CZ (1) | CZ299229B6 (enExample) |
| DE (1) | DE69804865T2 (enExample) |
| DK (1) | DK1051159T3 (enExample) |
| ES (1) | ES2175663T3 (enExample) |
| HU (1) | HUP0004363A3 (enExample) |
| IL (1) | IL136196A (enExample) |
| NO (1) | NO20003674L (enExample) |
| NZ (1) | NZ505648A (enExample) |
| PL (1) | PL189654B1 (enExample) |
| PT (1) | PT1051159E (enExample) |
| SI (1) | SI1051159T1 (enExample) |
| SK (1) | SK284839B6 (enExample) |
| TR (1) | TR200001717T2 (enExample) |
| UA (1) | UA68372C2 (enExample) |
| WO (1) | WO1999037289A1 (enExample) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE10203195A1 (de) * | 2002-01-25 | 2003-08-07 | Zentaris Ag | Verwendung von Alkylphosphocholinen in der Präventivbehandlung von Protozoenerkrankungen |
| US7887817B2 (en) * | 2002-01-25 | 2011-02-15 | Aeterna Zentaris Gmbh | Process for preventing protozoal diseases |
| WO2003090757A1 (en) * | 2002-04-26 | 2003-11-06 | Rudolf Perl | Pharmaceutical compositions of phospholipid derivatives |
| US8383605B2 (en) | 2002-07-30 | 2013-02-26 | Aeterna Zentaris Gmbh | Use of alkylphosphocholines in combination with antimetabolites for the treatment of benign and malignant oncoses in humans and mammals |
| UA82322C2 (uk) * | 2002-07-30 | 2008-04-10 | Центаріс Гмбх | Застосування алкілфосфохолінів в комбінації з протипухлинними лікарськими засобами |
| DK1663197T3 (da) | 2003-09-09 | 2008-01-07 | Fumapharm Ag | Anvendelse af fumarsyrederivater til behandling af hjerteinsuffiens og astma |
| SI1799196T1 (sl) | 2004-10-08 | 2016-10-28 | Forward Pharma A/S | Farmacevtski sestavki z nadzorovanim sproščanjem, obsegajoči ester fumarne kisline |
| US8703179B2 (en) * | 2006-05-11 | 2014-04-22 | Kimberly-Clark Worldwide, Inc. | Mucosal formulation |
| WO2010020276A1 (en) * | 2008-08-19 | 2010-02-25 | Orphanidis Pharma Research Gmbh | Treatment of coccidian parasites |
| US8383607B2 (en) | 2010-03-31 | 2013-02-26 | Aeterna Zentaris Gmbh | Perifosine and capecitabine as a combined treatment for cancer |
| BR112013012652A2 (pt) | 2010-11-22 | 2016-09-06 | Dafra Pharma Res & Dev Bvba | forma de dosagem sólida de oleil fosfocolina para administração oral, forma de dosagem sólida, e método para a preparação de uma forma de dosagem sólida |
| CN111298120A (zh) | 2011-06-24 | 2020-06-19 | 格里生物公司 | 炎性病症的预防和治疗 |
| EP2983709A1 (en) * | 2013-04-08 | 2016-02-17 | Academisch Medisch Centrum | Miltefosin or perifosin for use in the treatment of ibd |
| WO2016042372A1 (en) | 2014-09-17 | 2016-03-24 | Steer Engineering Private Limited | Effervescent composition and method of making it |
| CN104473941A (zh) * | 2014-12-20 | 2015-04-01 | 长沙佰顺生物科技有限公司 | 一种含有米替福新的药物制剂及其制备方法 |
| US11219594B2 (en) | 2015-12-12 | 2022-01-11 | Steerlife India Private Limited | Effervescent compositions of metformin and processes for preparation thereof |
| BR112021020389A2 (pt) * | 2019-04-12 | 2021-12-07 | Oblita Therapeutics Bvba | Formulações de dosagem em comprimidos de oleil fosfocolina |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE888444C (de) * | 1951-11-10 | 1953-08-31 | Benckiser Gmbh Joh A | Verfahren zum Tablettieren von hygroskopischen Praeparaten |
| IE59778B1 (en) * | 1985-12-04 | 1994-04-06 | Max Planck Gesellschaft | Medicament with anti-tumour action containing hexadecylphosphocholine |
| US4762658A (en) * | 1986-10-08 | 1988-08-09 | Central Soya Company, Inc. | Method of tableting of de-oiled phosphatides (lecithin) |
| US5290769A (en) * | 1989-09-27 | 1994-03-01 | Asta Pharma Aktiengesellschaft | Use of hexadecylphosphocholine for the treatment of psoriasis |
| EP0419998A3 (en) * | 1989-09-27 | 1991-10-23 | Asta Pharma Aktiengesellschaft | Use of alkylphosphonic acid derivatives for the treatment of psoriasis |
| DE4132344A1 (de) * | 1991-09-27 | 1993-04-01 | Max Planck Gesellschaft | Verfahren zur herstellung eines arzneimittels zur oralen oder topischen verabreichung bei der behandlung von leishmaniasis |
-
1998
- 1998-01-22 CA CA002318260A patent/CA2318260C/en not_active Expired - Fee Related
- 1998-01-22 IL IL13619698A patent/IL136196A/en not_active IP Right Cessation
- 1998-01-22 WO PCT/EP1998/000345 patent/WO1999037289A1/en not_active Ceased
- 1998-01-22 EP EP98904121A patent/EP1051159B1/en not_active Expired - Lifetime
- 1998-01-22 DE DE69804865T patent/DE69804865T2/de not_active Expired - Lifetime
- 1998-01-22 KR KR10-2000-7008029A patent/KR100517399B1/ko not_active Expired - Fee Related
- 1998-01-22 PL PL98342838A patent/PL189654B1/pl not_active IP Right Cessation
- 1998-01-22 UA UA2000084909A patent/UA68372C2/uk unknown
- 1998-01-22 CN CNB988125714A patent/CN100413492C/zh not_active Expired - Fee Related
- 1998-01-22 SK SK986-2000A patent/SK284839B6/sk unknown
- 1998-01-22 AT AT98904121T patent/ATE215817T1/de not_active IP Right Cessation
- 1998-01-22 HU HU0004363A patent/HUP0004363A3/hu unknown
- 1998-01-22 TR TR2000/01717T patent/TR200001717T2/xx unknown
- 1998-01-22 JP JP2000528271A patent/JP2002501015A/ja active Pending
- 1998-01-22 ES ES98904121T patent/ES2175663T3/es not_active Expired - Lifetime
- 1998-01-22 DK DK98904121T patent/DK1051159T3/da active
- 1998-01-22 SI SI9830205T patent/SI1051159T1/xx unknown
- 1998-01-22 AU AU62121/98A patent/AU756805B2/en not_active Ceased
- 1998-01-22 CZ CZ20002596A patent/CZ299229B6/cs not_active IP Right Cessation
- 1998-01-22 PT PT98904121T patent/PT1051159E/pt unknown
- 1998-01-22 NZ NZ505648A patent/NZ505648A/xx unknown
- 1998-01-22 BR BR9814772-2A patent/BR9814772A/pt not_active Application Discontinuation
-
2000
- 2000-07-18 NO NO20003674A patent/NO20003674L/no not_active Application Discontinuation
- 2000-07-24 US US09/624,890 patent/US6544551B1/en not_active Expired - Lifetime
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PL342838A1 (en) | Solid pharmaceutical compositions containing miltefosine for oral administration in the treatment of leishmaniasis | |
| BR9914251A (pt) | Formulações orais de liberação sustentada | |
| BG104727A (en) | Pharmaceutical composition of topiramate | |
| AR021844A1 (es) | Derivados de propanolamina aril-sustituidos, procedimientos para su preparacion, medicamentos que contienen estos compuestos y su utilizacion | |
| ATE429210T1 (de) | Orale flüssige zusammensetzungen | |
| IL119989A0 (en) | Pharmaceutical compositions for oral treatment of multiple sclerosis | |
| YU92501A (sh) | Levodop/karbidop/entakapon farmaceutski preparat | |
| ATE486587T1 (de) | Formulierungen zur oralen verabreichung von wirkstoffen | |
| GEP20032925B (en) | Benzothiepines Having Activity As Inhibitors of Ileal Bile Acid Transport and Taurocholate Uptake | |
| FI20011703A7 (fi) | Jodidia ja jodaattia sisältävä stabiloitu oraalinen farmaseuttinen koostumus sekä menetelmä | |
| MXPA03010549A (es) | Formas de dosificacion de oxcarbazepina. | |
| BG105292A (en) | Novel hydrate forms of alendronate sodium, processes for manufacture thereof, and pharmaceutical compositions thereof | |
| BR9913072A (pt) | Sistemas de anel azacìclico, composição farmacêutica, e, processo para induzir a analgesia | |
| BR9909958A (pt) | Formulação farmacêutica, respectivos processo de preparação e uso e método de tratamento ou prevenção de distúrbios ósseos | |
| MY119090A (en) | Synthetic polysaccharides, process for their preparation and pharmaceutical compositions containing them | |
| BRPI9916820B8 (pt) | composição compreendendo 9[2[[bis[(pivaloilóxi)metil]fosfono]metóxi]etil]adenina, comprimido ou cápsula e método | |
| BR0114395A (pt) | Composição farmacêutica para administração por suprimento via oral | |
| AU2003271811A8 (en) | Novel derivatives of 4,4'-dithiobis-(3-aminobutane-1-sulphonates) and compositions containing same | |
| CA2344686A1 (en) | High purity composition comprising (7.alpha.,17.alpha.)-17-hydroxy-7-methyl-19-nor-17-pregn-5(10)-en-20-yn-3-one | |
| ES2172179T3 (es) | Composiciones farmaceuticas de liberacion controlada que contienen tiagabina. | |
| BG104673A (en) | Solid pharmaceutical compositions containing miltefosine for oral administration in the treatment of leishmaniasis | |
| BR0307021A (pt) | Uso de alquilfosfocolinas no tratamento preventivo de doenças de protozoários | |
| BR0016646A (pt) | Método para tratar um paciente que sofre de dor, e, composição farmacêutica | |
| UA32939A (uk) | Сульфокамфокаїн, спосіб його виготовлення і спосіб підготовки обладнання для виготовлення сульфокамфокаїну | |
| ECSP993181A (es) | Procedimiento para la preparacion de una composicion de alta pureza de (7alfa, 17alfa)- 17 - hidroxi-7-19-nor-17- pregn-5(10) -en -20-in-3-ona |